Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMenéndez Torre, Edelmiro
dc.contributor.authorGutiérrez-Hurtado, Alba
dc.contributor.authorOllero, María Dolores
dc.contributor.authorIrigaray, Ana
dc.contributor.authorMartín, Patricia
dc.contributor.authorParra Ramírez, Paola
dc.contributor.authorBiagetti, Betina
dc.date.accessioned2024-07-08T06:24:44Z
dc.date.available2024-07-08T06:24:44Z
dc.date.issued2024-06-17
dc.identifier.citationMenéndez-Torre EL, Gutiérrez-Hurtado A, Ollero MD, Irigaray A, Martín P, Parra P, et al. Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study. Front Endocrinol (Lausanne). 2024 Jun 17;15:1413810.
dc.identifier.issn1664-2392
dc.identifier.urihttps://hdl.handle.net/11351/11676
dc.descriptionRathke’s cleft cyst; Transsphenoidal surgery; Visual impairment
dc.description.abstractRathke’s cleft cysts (RCC) are a common type of lesion found in the sellar or suprasellar area. They are usually monitored clinically, but in some cases, surgery may be required. However, their natural progression is not yet well understood, and the outcomes of surgery are uncertain. The objective of this study is to evaluate the natural history of Rathke’s cleft cysts in patients who are clinically monitored without treatment, and to determine the outcomes of surgery and the incidence of recurrences over time. Design and patients: National multicentric study of patients diagnosed of Rathke’s cleft cyst (RCC- Spain) from 2000 onwards and followed in 15 tertiary centers of Spain. A total of 177 patients diagnosed of RCC followed for 67.3 months (6–215) and 88 patients who underwent surgery, (81 patients underwent immediate surgery after diagnosis and 7 later for subsequent growth) followed for 68.8 months (3–235). Results: The cyst size remained stable or decreased in 73.5% (133) of the patients. Only 44 patients (24.3%) experienced a cyst increase and 9 of them (5.1%) experienced an increase greater than 3 mm. In most of the patients who underwent surgery headaches and visual alterations improved, recurrence was observed in 8 (9.1%) after a median time of 96 months, and no predictors of recurrence were discovered. Conclusions: Rathke’s cleft cysts without initial compressive symptoms have a low probability of growth, so conservative management is recommended. Patients who undergo transsphenoidal surgery experience rapid clinical improvement, and recurrences are infrequent. However, they can occur after a long period of time, although no predictors of recurrence have been identified.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Endocrinology;15
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectAvaluació de resultats (Assistència sanitària)
dc.subjectQuistos
dc.subjectSistema nerviós central - Càncer - Cirurgia
dc.subjectHipòfisi
dc.subject.meshTreatment Outcome
dc.subject.meshCentral Nervous System Cysts
dc.subject.mesh/surgery
dc.subject.meshPituitary Neoplasms
dc.titleNatural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fendo.2024.1413810
dc.subject.decsresultado del tratamiento
dc.subject.decsquistes del sistema nervioso central
dc.subject.decs/cirugía
dc.subject.decsneoplasias hipofisarias
dc.relation.publishversionhttps://doi.org/10.3389/fendo.2024.1413810
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Menéndez-Torre EL] Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain. Grupo ENDO, Instituto de Investigación Biomédica del Principado de Asturias (ISPA), Oviedo, Spain. Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain. [Gutiérrez-Hurtado A] Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain. [Ollero MD, Irigaray A] Department of Endocrinology and Nutrition, Hospital Universitario de Navarra, Pamplona, Spain. [Martín P, Parra P] Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. [Biagetti B] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid38952395
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record